Preview Mode Links will not work in preview mode

Jul 30, 2025

Featuring an interview with Ms Kathleen D Burns, including the following topics:

  • Case: A man in his early 70s with metastatic hormone-sensitive prostate cancer who received an androgen receptor inhibitor in combination with androgen deprivation therapy (0:00)
  • Case: A man in his early 70s with metastatic castration-resistant prostate cancer (mCRPC) who received olaparib in combination with abiraterone (23:20)
  • Case: A man in his mid 70s with mCRPC who received lutetium Lu 177 vipivotide tetraxetan (33:44)

NCPD information and select publications